Champions Oncology Stock Technical Analysis
| CSBR Stock | USD 4.90 0.23 4.48% |
As of the 7th of May, Champions Oncology shows the risk adjusted performance of (0.03), and Mean Deviation of 1.98. Champions Oncology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed thirteen technical drivers for Champions Oncology, which can be compared to its peers. Please confirm Champions Oncology risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Champions Oncology is priced correctly, providing market reflects its regular price of 4.9 per share. Given that Champions Oncology has information ratio of (0.08), we suggest you to validate Champions Oncology's prevailing market performance to make sure the company can sustain itself at a future point.
Champions Oncology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Champions, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ChampionsChampions |
Champions Oncology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.75 | Hold | 1 | Odds |
Most Champions analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Champions stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Champions Oncology, talking to its executives and customers, or listening to Champions conference calls.
Champions Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Champions Oncology Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Champions Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Champions Oncology Trend Analysis
Use this graph to draw trend lines for Champions Oncology. You can use it to identify possible trend reversals for Champions Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Champions Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Champions Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Champions Oncology applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Champions Oncology market price will keep on failing further. It has 122 observation points and a regression sum of squares at 14.87, which is the sum of squared deviations for the predicted Champions Oncology price change compared to its average price change.About Champions Oncology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Champions Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Champions Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Champions Oncology price pattern first instead of the macroeconomic environment surrounding Champions Oncology. By analyzing Champions Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Champions Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Champions Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 0.8 | 1.74 | 1.57 | 1.75 | Receivables Turnover | 5.16 | 6.72 | 7.73 | 7.35 |
Champions Oncology May 7, 2024 Technical Indicators
Most technical analysis of Champions help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Champions from various momentum indicators to cycle indicators. When you analyze Champions charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.2817 | |||
| Mean Deviation | 1.98 | |||
| Coefficient Of Variation | (1,801) | |||
| Standard Deviation | 2.73 | |||
| Variance | 7.47 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | 0.2717 | |||
| Maximum Drawdown | 11.67 | |||
| Value At Risk | (5.03) | |||
| Potential Upside | 4.75 | |||
| Skewness | 0.2361 | |||
| Kurtosis | 0.8017 |
Champions Oncology May 7, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Champions stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,167 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 4.83 | ||
| Day Typical Price | 4.85 | ||
| Price Action Indicator | (0.04) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Champions Oncology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.Note that the Champions Oncology information on this page should be used as a complementary analysis to other Champions Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Champions Stock analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Champions Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Champions Oncology. If investors know Champions will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Champions Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Earnings Share (0.72) | Revenue Per Share 3.634 | Quarterly Revenue Growth (0.06) | Return On Assets (0.17) |
The market value of Champions Oncology is measured differently than its book value, which is the value of Champions that is recorded on the company's balance sheet. Investors also form their own opinion of Champions Oncology's value that differs from its market value or its book value, called intrinsic value, which is Champions Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Champions Oncology's market value can be influenced by many factors that don't directly affect Champions Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Champions Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Champions Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Champions Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.